Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Modulation of IgG1 immunoeffector function by glycoengineering of the GDP‐fucose biosynthesis pathway
Ist Teil von
Biotechnology and bioengineering, 2018-03, Vol.115 (3), p.705-718
Ort / Verlag
United States: Wiley Subscription Services, Inc
Erscheinungsjahr
2018
Quelle
Wiley Online Library
Beschreibungen/Notizen
Cross‐linking of the Fcγ receptors expressed on the surface of hematopoietic cells by IgG immune complexes triggers the activation of key immune effector mechanisms, including antibody‐dependent cell mediated cytotoxicity (ADCC). A conserved N‐glycan positioned at the N‐terminal region of the IgG CH2 domain is critical in maintaining the quaternary structure of the molecule for Fcγ receptor engagement. The removal of a single core fucose residue from the N‐glycan results in a considerable increase in affinity for FcγRIIIa leading to an enhanced receptor‐mediated immunoeffector function. The enhanced potency of the molecule translates into a number of distinct advantages in the development of IgG antibodies for cancer therapy. In an effort to significantly increase the potency of an anti‐CD20, IgG1 molecule, we selectively targeted the de novo GDP‐fucose biosynthesis pathway of the host CHO cell line to generate >80% afucosylated IgG1 resulting in enhanced FcγRIIIa binding (13‐fold) and in vitro ADCC cell‐based activity (11‐fold). In addition, this effective glycoengineering strategy also allowed for the utilization of the alternate GDP‐fucose salvage pathway to provide a fast and efficient mechanism to manipulate the N‐glycan fucosylation level to modulate IgG immune effector function.
A novel glycoengineering approach to manipulate the metabolic GDP‐fucose biosynthesis pathway of an industrial CHO cell line, to produce recombinant IgG1's with enhanced potency.